FDA grants clearance for plaque-clearing device
The U.S. FDA has granted clearance to Cardiovascular Systems’ device, Diamond 360, which clears plaque from blood vessels.
According to the St. Paul, Minn.-based company, its Diamondback 360 can be used to treat peripheral arterial disease, in which plaque blocks large blood vessels in the legs, arms and feet.
The device uses a diamond-coated crown which orbits at high speeds to safely sand away calcified plaque as well as other common types of plaque, according to the company.
According to the St. Paul, Minn.-based company, its Diamondback 360 can be used to treat peripheral arterial disease, in which plaque blocks large blood vessels in the legs, arms and feet.
The device uses a diamond-coated crown which orbits at high speeds to safely sand away calcified plaque as well as other common types of plaque, according to the company.